Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.62 |
| ▸ | TP53 | P04637 | 9/20 | 0.56 |
| ▸ | MAPT | P10636 | 8/20 | 0.56 |
| ▸ | POLB | P06746 | 3/20 | 0.56 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.54 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.54 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.54 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20525442 | 1.00 | LMNA (0.62) | LMNATP53MAPTPOLBPABPC1 | |
| SCHEMBL20525402 | 1.00 | LMNA (0.62) | LMNATP53MAPTPOLBPABPC1 | |
| SCHEMBL20525374 | 0.92 | LMNA (0.67) | LMNATP53MAPTPOLBPABPC1 | |
| SCHEMBL20525375 | 0.92 | LMNA (0.67) | LMNATP53MAPTPOLBPABPC1 | |
| SCHEMBL20525437 | 0.92 | LMNA (0.67) | LMNATP53MAPTPOLBPABPC1 | |
| SCHEMBL20525444 | 0.81 | POLB (0.74) | LMNATP53MAPTPOLBPABPC1 | |
| SCHEMBL16431347 | 0.79 | DRD2 (0.68) | LMNATP53MAPTPOLBPABPC1 | |
| SCHEMBL17837255 | 0.79 | THRB (0.50) | TP53MAPTPOLBTHRB | |
| SCHEMBL17837230 | 0.79 | THRB (0.50) | TP53MAPTPOLBTHRB | |
| SCHEMBL17837257 | 0.79 | THRB (0.50) | TP53MAPTPOLBTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3027612-B1 | 11-OXO-10,11-DIHYDRODIBENZO[B,F][1,4]THIAZEPINE S-OXIDE DERIVATIVES AND THEIR USE AS DOPAMINE D2 RECEPTOR ANTAGONISTS | US HEALTH (US) | 2018-10-10 | — | — | EP | claimed |